title: Treatment of hormone-refractory prostate cancer, HRPC, remains challenging.
authors.forename: S John
authors.initials: SJ
authors.lastname: Weroha
authors.forename: J Fernando
authors.initials: JF
authors.lastname: Quevedo
mesh_terms: D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D003520:Cyclophosphamide